Alan Dunton

Alan Dunton

Directeur/Membre du Conseil chez CORMEDIX INC.

Fortune : 595 501 $ au 31/05/2026

71 ans
Health Technology
Consumer Services
Commercial Services

Profil

Dr. Alan W.
Dunton
, MD, is an Independent Non-Executive Director at Recce Pharmaceuticals Ltd., an Independent Director at CorMedix, Inc., an Independent Director at Palatin Technologies, Inc. and an Independent Director at Oragenics, Inc. He is on the Board of Directors at Recce Pharmaceuticals Ltd., CorMedix, Inc., Cytogel Pharma LLC, Palatin Technologies, Inc., Oragenics, Inc. and ActivBiotics, Inc. Dr. Dunton was previously employed as an Independent Non-Executive Director by Regeneus Ltd., a SVP-Regulatory Affairs, Research & Development by Purdue Pharma LP, a Non-Executive Director by Bionomics Ltd., a Chief Medical Officer by Derma Sciences, Inc., a Non-Executive Chairman by EpiCept Corp., a Chief Medical Officer by Marina Biotech, Inc., a Managing Director by Panacos Pharmaceuticals, Inc., an Independent Director by Targacept, Inc., a Principal Owner by Danerius LLC, a President & Chief Executive Officer by Metaphore Pharmaceuticals, Inc., a President, Chief Operating Officer & Director by Emisphere Technologies, Inc., a President & Managing Director by The Janssen Research Foundation, a Senior Executive by Johnson & Johnson, a Vice President-Clinical Research & Development by Syntex Corp., a Vice President-Clinical Research & Development by Ciba-Geigy Corp., a Vice President-Clinical Research & Development by Hoffmann-La Roche, Inc., a Chairman by Janssen-Cilag International NV, He received his undergraduate degree from State University of New York at Buffalo and a doctorate degree from New York University School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
13/04/2026 40 250 ( 0,05 % ) 339 710 $ 31/05/2026
09/12/2025 14 081 ( 0,79 % ) 197 416 $ 31/05/2026
30/06/2025 146 288 ( 0,05 % ) 57 889 $ 31/05/2026
30/04/2026 802 ( 0,02 % ) 486 $ 31/05/2026

Postes actifs de Alan Dunton

SociétésPosteDébut
CORMEDIX INC. Directeur/Membre du Conseil 01/03/2019
ORAGENICS, INC. Directeur/Membre du Conseil 01/04/2011
PALATIN TECHNOLOGIES, INC. Directeur/Membre du Conseil 22/06/2011
RECCE PHARMACEUTICALS LTD Directeur/Membre du Conseil 14/07/2020
Directeur/Membre du Conseil 01/10/2018
Directeur/Membre du Conseil 01/01/2007

Anciens postes connus de Alan Dunton

SociétésPosteFin
REGENEUS LTD Directeur/Membre du Conseil 25/02/2021
Directeur Technique/Scientifique/R&D 01/03/2018
ADHERA THERAPEUTICS, INC. Directeur Technique/Scientifique/R&D 21/02/2017
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Alan Dunton

Formation de Alan Dunton

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

71

Relations au 1er degré

34

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées34

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Retail Trade

Consumer Services

Health Technology

Health Technology

Health Technology

The Janssen Research Foundation

R.W. Johnson Pharmaceutical Research Institute

Danerius LLC

Commercial Services

Johnson & Johnson Pharmaceutical Group

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Alan Dunton
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇